Phase I/II trial begins for SpyGlass intraocular drug delivery implant
The platform consists of an intraocular lens with drug-eluting pads and is designed so that patients need not self-administer eye drops post-surgery.
The platform consists of an intraocular lens with drug-eluting pads and is designed so that patients need not self-administer eye drops post-surgery.